The inherited expression of Isl-1/Pax-6/Nkx6.1/Somatostatin transcripts in h-ASCs, its ease in availability and autologous origin, make it an eminent candidate for cell replacement therapy in diabetes. This evidence concerns the gene SST and diabetes mellitus.